• to reduce the risk of major cardiovascular (coronary heart and blood vessel) difficulties in Grown ups with sort two diabetes and cardiovascular diseaseIn Oct 2024, Novo Nordisk published a analyze on scientific journal Character about a novel glucose-sensitive insulin NNC2215 that could minimize the chance of hypoglycemia in animal styles.[six